Addus HomeCare (NASDAQ:ADUS) PT Raised to $118.00

Addus HomeCare (NASDAQ:ADUS) had its price objective increased by investment analysts at Bank of America from $115.00 to $118.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Bank of America‘s target price indicates a potential upside of 10.19% from the company’s previous close.

A number of other equities research analysts have also recently issued reports on ADUS. Royal Bank of Canada reiterated an “outperform” rating and set a $102.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 29th. Oppenheimer restated an “outperform” rating and issued a $118.00 price target on shares of Addus HomeCare in a research note on Tuesday, March 26th. Barclays cut Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a research note on Tuesday, April 23rd. Finally, William Blair restated an “outperform” rating on shares of Addus HomeCare in a research note on Monday, February 5th. One equities research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $106.57.

Addus HomeCare Trading Up 2.4 %

Shares of Addus HomeCare stock opened at $107.09 on Tuesday. Addus HomeCare has a 12-month low of $78.35 and a 12-month high of $107.54. The stock has a market cap of $1.75 billion, a P/E ratio of 27.89, a P/E/G ratio of 1.94 and a beta of 0.96. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18. The business’s 50 day moving average is $99.03 and its 200-day moving average is $92.71.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The company had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. During the same quarter in the prior year, the business posted $0.84 EPS. The business’s revenue was up 11.6% compared to the same quarter last year. Equities research analysts predict that Addus HomeCare will post 4.38 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. grew its position in Addus HomeCare by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock worth $116,753,000 after buying an additional 38,876 shares in the last quarter. Wellington Management Group LLP raised its stake in Addus HomeCare by 1.2% in the fourth quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock valued at $74,135,000 after purchasing an additional 9,548 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Addus HomeCare by 0.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 698,498 shares of the company’s stock valued at $64,857,000 after purchasing an additional 5,654 shares in the last quarter. TimesSquare Capital Management LLC raised its stake in Addus HomeCare by 9.8% in the first quarter. TimesSquare Capital Management LLC now owns 289,998 shares of the company’s stock valued at $29,968,000 after purchasing an additional 25,910 shares in the last quarter. Finally, Summit Creek Advisors LLC increased its stake in Addus HomeCare by 14.5% in the third quarter. Summit Creek Advisors LLC now owns 288,158 shares of the company’s stock valued at $24,548,000 after acquiring an additional 36,578 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.